Comparison of proteolytic, cytotoxic and anticoagulant properties of chromatographically fractionated bromelain to un-fractionated bromelain.

Badar, Samina; Azarkan, Mohamed; Mekkawy, Ahmed H; Akhter, Javed; Pillai, Krishna; El Mahyaoui, Rachida; Ke, Kevin; Cavanaugh, Lauren; Morris, David L

Badar, Samina; Azarkan, Mohamed; Mekkawy, Ahmed H; Akhter, Javed; Pillai, Krishna; El Mahyaoui, Rachida; Ke, Kevin; Cavanaugh, Lauren; Morris, David L.

Afiliación

Badar S; Department of Surgery, University of New South Wales, St. George Hospital Kogarah, NSW, Australia.
Azarkan M; Service de Chimie Générale I (CP 609), Protein Chemistry Unit, Faculty of Medicine, Université Libre de Bruxelles (ULB) Brussels, Belgium.
Mekkawy AH; Department of Surgery, University of New South Wales, St. George Hospital Kogarah, NSW, Australia.
Akhter J; Mucpharm Pty Ltd Australia.
Pillai K; Department of Surgery, University of New South Wales, St. George Hospital Kogarah, NSW, Australia.
El Mahyaoui R; Mucpharm Pty Ltd Australia.
Ke K; Department of Surgery, University of New South Wales, St. George Hospital Kogarah, NSW, Australia.
Cavanaugh L; Mucpharm Pty Ltd Australia.
Morris DL; Service de Chimie Générale I (CP 609), Protein Chemistry Unit, Faculty of Medicine, Université Libre de Bruxelles (ULB) Brussels, Belgium.

Am J Transl Res ; 13(5): 4309-4321, 2021.

Article en En | MEDLINE | ID: mdl-34150016

Palabras clave

Bromelain; cancer; coagulation; cytotoxic; proteolysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Am J Transl Res Año: 2021 Tipo del documento: Article País de afiliación: Australia